BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8648262)

  • 1. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.
    Tsafack A; Loyevsky M; Ponka P; Cabantchik ZI
    J Lab Clin Med; 1996 Jun; 127(6):574-82. PubMed ID: 8648262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
    Richardson DR; Milnes K
    Blood; 1997 Apr; 89(8):3025-38. PubMed ID: 9108424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
    Tsafack A; Golenser J; Libman J; Shanzer A; Cabantchik ZI
    Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
    Richardson DR; Tran EH; Ponka P
    Blood; 1995 Dec; 86(11):4295-306. PubMed ID: 7492790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
    Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
    Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis.
    Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
    Blood; 1994 Aug; 84(3):910-5. PubMed ID: 8043872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation.
    Darnell G; Richardson DR
    Blood; 1999 Jul; 94(2):781-92. PubMed ID: 10397746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs.
    Becker E; Richardson DR
    J Lab Clin Med; 1999 Nov; 134(5):510-21. PubMed ID: 10560945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
    Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
    J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool.
    Walcourt A; Kurantsin-Mills J; Kwagyan J; Adenuga BB; Kalinowski DS; Lovejoy DB; Lane DJ; Richardson DR
    J Inorg Biochem; 2013 Dec; 129():43-51. PubMed ID: 24028863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites.
    Walcourt A; Loyevsky M; Lovejoy DB; Gordeuk VR; Richardson DR
    Int J Biochem Cell Biol; 2004 Mar; 36(3):401-7. PubMed ID: 14687919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture.
    Baker E; Richardson D; Gross S; Ponka P
    Hepatology; 1992 Mar; 15(3):492-501. PubMed ID: 1544632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.
    Chen YL; Kong X; Xie Y; Hider RC
    J Inorg Biochem; 2018 Mar; 180():194-203. PubMed ID: 29329026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable inhibitory effects on the formation of dinitrosyl iron complexes by deferoxamine and salicylaldehyde isonicotinoyl hydrazone in K562 cells.
    Meczynska S; Lewandowska H; Sochanowicz B; Sadlo J; Kruszewski M
    Hemoglobin; 2008; 32(1-2):157-63. PubMed ID: 18274993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron chelators: mode of action as antimalarials.
    Cabantchik ZI; Glickstein H; Golenser J; Loyevsky M; Tsafack A
    Acta Haematol; 1996; 95(1):70-7. PubMed ID: 8604590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.
    Golenser J; Tsafack A; Amichai Y; Libman J; Shanzer A; Cabantchik ZI
    Antimicrob Agents Chemother; 1995 Jan; 39(1):61-5. PubMed ID: 7695330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.
    Potuckova E; Jansova H; Machacek M; Vavrova A; Haskova P; Tichotova L; Richardson V; Kalinowski DS; Richardson DR; Simunek T
    PLoS One; 2014; 9(2):e88754. PubMed ID: 24586383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.
    Macková E; Hrušková K; Bendová P; Vávrová A; Jansová H; Hašková P; Kovaříková P; Vávrová K; Simůnek T
    Chem Biol Interact; 2012 May; 197(2-3):69-79. PubMed ID: 22521999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells.
    Link G; Ponka P; Konijn AM; Breuer W; Cabantchik ZI; Hershko C
    Blood; 2003 May; 101(10):4172-9. PubMed ID: 12511418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.